国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

日本Chiome Bioscience  
Chiome公司，擅長(cháng)于抗體技術(shù)，稱(chēng)其技術(shù)平臺具有"加速藥物發(fā)現及推進(jìn)醫藥開(kāi)發(fā)"的潛能。該公司的"自主多元化文庫（Autonomously Diversifying Library，ADLib）"系統，能夠快速地產(chǎn)生抗體，在實(shí)驗室環(huán)境下僅需短短10天時(shí)間。

Chiome is a Japan-based biotech company specialized in antibody and technology development. It has developed an innovative and unique platform technology, ADLib?system, to which right Chiome co-owns with RIKEN Institute. Since 2008, it has been engaged in joint research and the generation of antibodies with a number of leading domestic and multinational pharmaceutical and diagnostic companies. Chiome offers ADLib?system to partners under a non-exclusive license to maximize the value of the technology. By leveraging this proprietary technology Chiome Bioscience believes it can make great contributions to pharmaceutical development.